Olink Holding AB (publ) (OLK)

Market Cap	2.38B
Revenue (ttm)	125.65M
Net Income (ttm)	-26.25M
Shares Out	119.10M
EPS (ttm)	-0.21
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	256,391
Open	19.66
Previous Close	19.96
Day's Range	19.50 - 20.04
52-Week Range	8.39 - 26.47
Beta	n/a
Analysts	Buy
Price Target	23.46 (+17.59%)
Earnings Date	Feb 21, 2023

About OLK

Olink Holding AB (publ) provides various products and services for the academic, government, biopharmaceutical, biotechnology, and other institutions that focuses on life science research. Its products include Olink Explore for cardiovascular and metabolic, oncology, neurology, or inflammation diseases; Olink Target product line; and Olink Focus product line that consists of custom developed solutions for customers that has identified various proteins of interest or a protein signature to focus on. The company's products also comprise Olink Sig...

• Industry: Diagnostics & Research
• Sector: Healthcare
• IPO Date: Mar 25, 2021
• Employees: 416
• Stock Exchange: NASDAQ
• Ticker Symbol: OLK

Financial Performance

In 2021, OLK's revenue was $94.97 million, an increase of 75.66% compared to the previous year's $54.07 million. Losses were -$38.34 million, 465.5% more than in 2020.

Analyst Forecast

According to 9 analysts, the average rating for OLK stock is "Buy." The 12-month stock price forecast is $23.46, which is an increase of 17.59% from the latest price.

Price Target

$23.46

(17.59% upside)

Analyst Consensus: Buy